Table 1.
| Antipsychotic | Very high | High | Moderate | Low | Negligible |
|---|---|---|---|---|---|
| daily dose |
(Ki < 1.0) |
(Ki 1.0–9.9) |
(Ki 10–99) |
(Ki 100–999) |
(Ki ≥1000) |
| Ziprasidone |
5HT2a (0.4) |
5HT1a (2.5) ** |
α1 (13) |
D1 (130) |
M1 (5100) |
| 120-160 mg |
5HT2c (0.7) |
D2 (3.1) |
D4 (32) |
α2 (310) |
|
| |
|
D3 (7.2) |
H1 (47) |
|
|
| |
|
5HT7 (9.3) |
NAuptake (48) |
|
|
| |
|
|
5HTuptake (53) |
|
|
| |
|
|
5HT6 (76) |
|
|
| Aripiprazole |
D2(0.3) ** |
5HT1a (1.7) ** |
D4 (44) |
|
M1 (>1000) |
| 15-30 mg |
D3(0.8) |
5HT2a(3.4) |
5HT2c (15) |
|
|
| |
|
|
5HT7 (39) |
|
|
| |
|
|
α1 (57) |
|
|
| |
|
|
H1 (61) |
|
|
| |
|
|
5HTuptake (98) |
|
|
| Risperidone |
5HT2a(0.3) |
α1 (1.4) |
5HT2c (10) |
5HT1A(210) |
5HTuptake (1400) |
| 4-6 mg |
|
D2 (2.2) |
H1 (19) |
D1(580) |
5HT6 (2000) |
| |
|
5HT7 (3.0) |
|
|
M1 (2800) |
| |
|
D3 (9.6) |
|
|
NAuptake (28,000) |
| |
|
D4 (8.5) |
|
|
|
| |
|
α2 (5.1) |
|
|
|
| Paliperidone |
|
5HT2a(1.0) |
α2 (17) |
5HT1A(590) |
M1 (3570) |
| 6-9 mg |
|
5HT7 (1.3) |
H1 (32) |
D1(670) |
|
| |
|
α1 (4.0) |
D4 (30) |
|
|
| |
|
D2 (4.8) |
5HT2c (71) |
|
|
| |
|
D3 (6.9) |
|
|
|
| Olanzapine |
|
H1(2.8) |
5HT2c (10) |
α2 (170) |
5HT1a (2100) |
| 10-20 mg |
|
5HT2a(3.3) |
5HT6 (10) |
5HT7 (250) |
NAuptake (2000) |
| |
|
M1(4.7) |
D2 (20) |
|
5HTuptake (>15,000) |
| |
|
|
D3 (45) |
|
|
| |
|
|
D1 (52) |
|
|
| |
|
|
α1 (54) |
|
|
| |
|
|
D4 (60) |
|
|
| Clozapine |
|
H1(1.8) |
5HT6 (11) |
D4 (54) |
5HTuptake (3900) |
| 200-500 mg |
|
M1(1.8) |
5HT2c (17) |
D2 (130) |
|
| |
|
α1 (4.0) |
α2 (33) |
5HT1a (140) ** |
|
| |
|
5HT2a (8.9) |
5HT7 (66) |
D3 (240) |
|
| |
|
|
|
D1 (290) |
|
| |
|
|
|
NAuptake (390) * |
|
| Quetiapine |
|
H1 (8.7) |
α1 (15) |
M1 (100) |
α2 (1000) |
| 400-800 mg |
|
|
|
D2 (180) |
D1 (1300) |
| |
|
|
|
5HT2a (220) |
5HT2c (1400) |
| |
|
|
|
5HT1a (230) ** |
5HT7 (1800) |
| |
|
|
|
D3 (320) |
D4 (2200) |
| |
|
|
|
NAuptake (680)* |
5HT6 (4100) |
| 5HTuptake (>18,000) |
* Quetiapine’s active metabolite N-desalkyl-quetiapine inhibits NA uptake (35 nM). Clozapine’s active metabolite N-desmethyl-clozapine also has a low affinity for NA uptake inhibition.
** Partial agonist. Quetiapine’s active metabolite N-desalkyl-quetiapine is a 5HT1a partial agonist (191 nM). Clozapine’s active metabolite N-desmethyl-clozapine is a 5HT1a partial agonist (105 nM).
5-HT: serotonin; D: dopamine; H: histamine; M: muscarinic cholinergic; α: alpha-adrenergic.
Lower values (shown in parentheses) indicate higher affinities at receptors or greater inhibition of pre-synaptic neurotransmitter uptake. Antipsychotics used in relatively small daily doses are unlikely to have clinical effects at receptors for which they have low affinity, unlike antipsychotics used at high daily doses.